Home » Newsletters » BioWorld

BioWorld

Aug. 2, 1993

View Archived Issues

SKB TO MARKET THERATECH'S TESTOSTERONE PATCH

REGENERON FILES FOR OFFERING

APPOINTMENTS AND ADVANCEMENTS

TELOR BEGINS PHASE II TRIALS

NEW WAY TO INHIBIT GENE EXPRESSION

HOUSTON BIOTECH DEBUTS WITH $3.3 MILLION IPO

ORPHAN DRUG TAX CREDIT REVIVED

CYGNUS FILES IND FOR MULTIPLE-DOSE PATCHES

LIFECORE ACQUIRES DENTAL IMPLANT COMPANY

BIOMATRIX LICENSES EYE FLUID IN CANADA

AFFYMAX, ALZA FORMALIZE DEVELOPMENT PROGRAM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...